Following a series of hearings last year, members of the Energy and Commerce Committee in the US House of Representatives early in 2015 issued sweeping biomedical proposals under the rubric, “21st Century Cures.” Chief among the goals of these pro-industry proposals are the following provisions: incorporate patient perspectives into the regulatory process and help address their unmet medical needs; build the foundation for twenty-first century medicine; streamline clinical trials; support continued innovation at federal public health agencies; and modernize medical product regulation, according to committee chairman Fred Upton (R-MI) and Representative Dianna DeGette (D-CO). Another component of these proposals, aimed mainly to benefit young scientists, calls for establishing a public-private 21st Century Cures Consortium that takes the Innovative Medicines Initiative in Europe as its model. For details, see http://energycommerce.house.gov/cures.